| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |